Chang-Wook Nam

Showing 1-6 of 6 articles

Coronary interventions

Clinical outcomes of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention By Coronary Flow Capacity Status in Stable Lesions

Hamaya R, Lee J, Hoshino M, Yonetsu T, Koo B, Escaned J, Kakuta T, Kanaji Y, Kanno Y, Hada M, Yuki H, Yamaguchi M, Ohya H, Sumino Y, Hirano H, Horie T, Usui E, Sugano A, Sugiyama T, Murai T, Lee T, Choi K, Hwang D, Park J, Jung J, Kim H, Jung HW, Cho Y-K, Yoon H-J, Song YB, Hahn J, Doh J, Nam C, Shin E, Hur S-H, Mejía-Rentería H, Lauri F, Goto S, Macaya F, McInerney A, Gravina G, Vera R, Gonzalo N, Jimenez-Quevedo P, Núñez-Gil I, Salinas P, Nombela-Franco L, Del Trigo M, Fernández-Ortíz A, Macaya C

July 7, 2020 | 10.4244/EIJ-D-20-00401

Coronary interventions

Influence of target vessel on prognostic relevance of fractional flow reserve after coronary stenting

Hwang D, Lee J, Lee H, Kim S, Nam C, Hahn J, Shin E, Matsuo A, Tanaka N, Matsuo H, Lee S, Doh J, Koo B

August 29, 2019 | 10.4244/EIJ-D-18-00913

Prognosis of deferred non-culprit lesions according to fractional flow reserve in patients with acute coronary syndrome

Lee J, Choi K, Koo B, Shin E, Nam C, Doh J, Hwang D, Park J, Zhang J, Lim H, Yoon M-H, Tahk S

October 11, 2017 | 10.4244/EIJ-D-17-00110

Coronary interventions

Safety and efficacy of intracoronary nicorandil as hyperaemic agent for invasive physiological assessment: a patient-level pooled analysis

Lee J, Kato D, Oi M, Toyofuku M, Takashima H, Waseda K, Amano T, Kurita A, Ishihara H, Lim W-H, Doh J, Nam C, Tanaka N, Koo B, Tanaka N

June 10, 2016 | 10.4244/EIJV12I2A34

Usefulness of combined intravascular ultrasound parameters to predict functional significance of coronary artery stenosis and determinants of mismatch

Cho Y-K, Nam C, Han J-K, Koo B, Doh J, Ben-Dor I, Waksman R, Pichard A, Murata N, Tanaka N, Lee C-H, Gonzalo N, Escaned J, Costa M, Kubo T, Akasaka T, Hu X, Wang J-A, Yang H-M, Yoon M-H, Tahk S, Yoon H-J, Chung I-S, Hur S-H, Kim K-B

June 19, 2015 | 10.4244/EIJV11I2A30

Hybrid iFR-FFR decision-making strategy: implications for enhancing universal adoption of physiology-guided coronary revascularisation

Petraco R, Park J, Sen S, Nijjer S, Malik I, Echavarría-Pinto M, Asrress K, Nam C, Macías E, Foale R, Sethi A, Mikhail G, Kaprielian R, Baker C, Lefroy D, Bellamy M, Al-Bustami M, Khan M, Gonzalo N, Hughes A, Francis D, Mayet J, Di Mario C, Redwood S, Escaned J, Koo B, Davies J

February 22, 2013 | 10.4244/EIJV8I10A179

1

Latest news

Special issue on PCR Valves e-Course; patient-centring the Heart Team, COVID and clinical trials...

Optimising the delivery of self-expanding valves according to vascular access

November 20, 2020

Fatal Acute Mesenteric Ischemia Following Transcatheter Aortic Valve Replacement

November 25, 2020

Patient preferences and Heart Team decision

November 20, 2020

Popular Tavi-A, TAILOR-PCI, ATPCI, PORTICO-IDE and more

(Thanks to the support of Biotronik)

November 12, 2020

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

Cardiovascular trials and COVID-19

Alexandra Lansky

November 25, 2020

This Week's JAA's: Win Ratio for Renal Denervation, Optimal strategy for NSTEMI in the very elderly, D-PUSH OCT Procedure...

November 24, 2020

Valvular disease